tiprankstipranks
pc:lutri

Lutris Pharma

27 Habarzel Street Tel Aviv, IL
https://www.lutris-pharma.com/
Lutris Pharma is a clinical stage biopharmaceutical company dedicated to enhancing anti-cancer therapies by mitigating cutaneous dose-limiting toxicity. The company is developing LUT014, a topical gel designed to alleviate EGFR inhibitor-induced acneiform rash, thereby potentially improving treatment efficacy and patient quality of life.

Leadership & Board

Current Number of Employees5
Current LinkedIn Followers1,068

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$30M
Total Amount Raised$30M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$30M
Latest Funding Amount$30M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Employee Trend

Lutris Pharma had 5 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
5Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Lutris Pharma had 1,068 followers as of April 6, 2026. The number of followers increased by 2 (0.19%) week-over-week.
1,068Latest Followers Count
2(0.19%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 28, 2025
Investment
$30.00M

Investors

Investor Name
Funding Round

Related News and Analysis